Philippe Arnaud
About Philippe Arnaud
Philippe Arnaud is the Director at Bristol Myers Squibb in Boudry, Neuchâtel, Suisse, with a background in Hematology and extensive expertise in CAR T-cell therapy.
Company
Philippe Arnaud is currently employed at Bristol Myers Squibb. He holds the position of Director and operates out of their office in Boudry, Neuchâtel, Suisse. Bristol Myers Squibb is known for its focus on innovative medicine, where Philippe contributes to the development and implementation of medical strategies, particularly in the field of Hematology.
Title
Philippe Arnaud serves as the Director at Bristol Myers Squibb. In his role, he oversees various medical strategies and operations within the organization, with a specific focus on Hematology.
Education and Expertise
Philippe Arnaud earned his Doctor of Medicine (MD) from Université Claude Bernard Lyon 1, specializing in Hematology. Since November 2014, he has been actively involved in Medical Affairs, focusing on Hematology, Lymphoma, and CAR T-cell therapy. His extensive expertise in CAR T-cell therapy highlights his role in advancing cutting-edge treatments in oncology.
Background
Philippe Arnaud has been working in the field of Medical Affairs since November 2014. His work has centered on Hematology, Lymphoma, and CAR T-cell therapy. This extensive experience has equipped him with a deep understanding of these areas, which he utilizes in his current role at Bristol Myers Squibb.